In this large retrospective analysis of a registry of >17,000 patients who underwent total hip arthroplasty, the overall incidence of PE was 0.4%, and mortality was 0.5%, neither of which differed by type of VTE prophylaxis utilized (ASA, heparin, warfarin, or mechanical). Given the overall low incidence of VTE in these patients, this study calls into question the utility of using medical thromboprophylaxis on all hip patients, and argues for a risk-stratified approach to VTE prophylaxis (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.